Home
>
National Drug Code (NDC)
>
Valcyte
Valcyte - 0004-0038-22 - (valganciclovir hydrochloride)
Drug Information of Valcyte
| Product NDC: | 0004-0038 |
| Proprietary Name: | Valcyte |
| Non Proprietary Name: | valganciclovir hydrochloride |
| Active Ingredient(s): | 450 mg/1 & nbsp; valganciclovir hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Valcyte
| Product NDC: | 0004-0038 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021304 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20010329 |
Package Information of Valcyte
| Package NDC: | 0004-0038-22 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0004-0038-22) |
NDC Information of Valcyte
| NDC Code | 0004-0038-22 |
| Proprietary Name | Valcyte |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0004-0038-22) |
| Product NDC | 0004-0038 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | valganciclovir hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20010329 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | VALGANCICLOVIR HYDROCHLORIDE |
| Strength Number | 450 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
